Publications
Borden WB, Davidson MH. In high and very high risk patients, is it true that when it comes to LDL-C, lower is better? Can a serum LDL-C be driven too low? --- Clinical Challenges in Dyslipidemia Management; in press
Borden WB, Davidson MH, Updating the Assessment of Cardiac Risk: Beyond Framingham. -- Reviews in Cardiovascular Medicine; in press
Borden WB, Coon PD, Lang RM.-- Atrial Septal Defects. eCLIPS: Echocardiography in Clinical Practice; in press
Takeuchi M, Borden WB, Nakai H, Nishikage T, Kokumani M, Nagakura T, Otami S, Lang RM, ---Reduced and Delayed Untwisting of the Left Ventricle in Patients With Hypertension and Left Ventriclar Hypertrophy- Eur Heart Journal 2007;28(22):2756-62
Borden WB, Lang RM.--- Cardiac Syndrome X: Building the Case. Current Cardiology Reports 2008; 10(3):209-210
Borden WB, Faxon DP.--- Facilitated Percutaneous Coronary Intervention. Journal -American College of Cardiology 2006; 48:1120-1128
Borden WB, Rich S, Gomberg M.---Success with Calcium-Channel Blockers in a Patient Who Failed Bostentan Therapy for Idiopathic Pulmonary Arterial Hypertension. Chest 2006; 130:306S-308S
Fennessy MM, Borden, WB. ---Clinical Benefits of Drug-Eluting Stents: Results From RAVEL and Beyond. Journal Cardiovascular Nurs 20063; 21(6):442-450
Arora V, Schneider JA, Borden WB, Humphrey HJ.-- Approach to routine interactions with industry: a primer for residents. Semin Med PRact 2005; 8:55-63
Borden WB, Tamargo RJ.-- George J Heuer M.D.: forgotten pioneer neurosurgeon at The Johns Hopkins Hospital. J Neurosurg 2002; 96: 1139-1146
Maier CC, Bhandool A, Borden WB, Yui K, Hayakawa K, Green MI. --- Unique molecular surface features of in vivo tolerized T cells. Proc Natl. Acad, Sci. 1998; 95:4499-4503
Kassahun H, Borden WB "Global Cardiovascular Disease: An Expanding Burden with Expanding Solutions." Perspectives in Public Health: Challenges for the 21st Century. Ed. Finkel, M.L. Westpott, CT: Praeger Press, forthcoming 2010. in press
Borden WB, Davidson MH.- Updating the Assessment of Cardiac Risk: Beyond Framingham. Reviews in Cardiovascular Medicine 2009; 10(2):63-71
Muchiteni T, Borden WB.- Improving Risk Factor Modification: A Global Approach. Current Cardiology Reports 2009; 11(6): 476-483
Borden WB, Davidson MH. " In high and very high risk patients, is it true that when it comes to LDL-c lower is better? Can a serum LDL-c be driven too low?" Clinical Challenges in Lipid Disorders. Ed. Toth PP and Sica AA Oxford: Clinical Publishing, 2008. 89-99
Borden, WB, Coon PD, Lang RM-- Atrial Septal Defects. eCLIPS: Echocardiography in Clinical Practice; in press
Takeuchi M, Borden WB, Nakai H, Nishikage T, Kokumani M, Nagakura T, Otami S, Lang RM-- Reduced and Delayed Untwisting of the Left Ventricle in Patients WIth Hypertension and Left Ventriclar Hypertrophy- Eur Heart Journal 2007; 28(22): 2756-62
Borden WB, Lang RM-- Cardiac Syndrome X: Building the Case. Current Cardiology Reports 2008; 10(3): 209-210
Borden WB, Faxon DP-- Facilitated Percutaneous Coronary Intervention. Journal- American College of Cardiology 2006; 48:1120-1128
Borden WB, Rich S, Gomberg M.-- Success with Calcium-Channel Blockers in a Patient Who Failed Bostentan Therapy for Idiopathic Pulmonary Arterial Hypertension. Chest 2006; 130:360S-308S
Fennessy MM, Borden, WB--- Clinical Benefits of Drug-Eluting Stents: Results From RAVEL and Beyond. Journal Cardiovascular Nurs 20063; 21(6):442-450
Arora V, Schneider JA, Borden WB, Humphrey HJ--Approach to routine interactions with industry: a primer for residents. Semin Med PRact 2005; 8:55-63
Borden WB, Tamargo RJ-- George J Heuer M.D.: forgottten pioneer neusurgeon at The Johns Hopkins Hospital. J Neurosurg 2002; 96: 1139-1146
Maier CC, Bhandool A, Borden WB, Yui K, Hayakawa K, Green MI-- Unique molecular surface features of in vivo tolerized T cells. Pro Natl. Acad, Sci. 1998; 95:4499-4503
